Trade TNYA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Tenaya Therapeutics, Inc. (TNYA) is trading at US$0.69, down 0.60% today as of Aug 28, 13:02 EDT. The company has a market capitalisation of US$156.36M. Over the past 52 weeks, TNYA has traded between US$0.53 and US$2.35. On Syfe you can trade TNYA with $0 commission and add it to your watchlist.
| Previous close | US$0.70 |
|---|---|
| Market cap | US$156.36M |
| 52-week range | US$0.53 – US$2.35 |
| Volume | 1.23M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. Its programs include TN-201, TN-401, and TN-301. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Newell Olson in 2016 and is headquartered in South San Francisco, CA.
Year: 2021
Tenaya Therapeutics Names Eric Hyllengren CFO
Jun 29, 1:09 PM · MT Newswires
Sector Update: Health Care Stocks Decline Thursday Afternoon
Mar 5, 7:00 PM · MT Newswires
Tenaya Therapeutics Signs Potential $1.13 Billion Deal With Alnylam
Mar 5, 2:33 PM · MT Newswires
Tenaya Therapeutics, Inc. (TNYA) stock is trading at US$0.69, -0.60% from the previous close of US$0.70.
The market cap for Tenaya Therapeutics, Inc. (TNYA) stock is approximately US$156.36M.
The 52-week high for Tenaya Therapeutics, Inc. (TNYA) stock is US$2.35.
The 52-week low for Tenaya Therapeutics, Inc. (TNYA) stock is US$0.53.
Tenaya Therapeutics, Inc. (TNYA) does not currently pay a dividend.
Stay on top of TNYA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
